Latest news from international institutions

Cannabis legislation in Europe

22.03.2017 - Ad hoc publication from the EMCDDA that answers some of the questions most often asked about cannabis legislation.


MDMB-CHMICA : risk assessment

27.02.2017 - MDMB-CHMICA has been the first synthetic cannabinoid receptor agonist to be risk-assessed by the EMCDDA on 22 July 2016.


The EMCDDA provide on its website a database on which you can search publications of interest by publication series, publication type, date, and keywords.

Drugs in Europe

2016 EMCDDA European Drug Report

- Drug facts, figures and analyses: across Europe and by country
- Latest trends and legal, political and social responses
- Selected issues: Vulnerable groups of young people; National drug-related research in Europe; Towards a better understanding of drug-related public expenditure in Europe

Country situation summaries

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) website has a concise overview for each EU Member State on their national drug situation, as well as legal texts in their original formats, an indispensable tool for monitoring and analysing legislative developments in the Member States.

The European Union and the drug phenomenon

The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.